HRSA Just Sent Out $525 Million for Home Visiting — the Largest MIECHV Award Year Ever. It Is Also the Second-to-Last One Currently Authorized.
October 6, 2026 · 9 min read
Granted Research Team · Editorial policy
While the federal research agencies spent September failing to get money out the door, one HHS program quietly had its best year in sixteen years of existence.
On October 5, 2026, the Health Resources and Services Administration announced more than $525 million in fiscal year 2026 awards under the Maternal, Infant, and Early Childhood Home Visiting (MIECHV) Program — the largest federal investment in the program's history. The money went to 56 state and jurisdiction recipients, and in a detail that deserves more attention than it has gotten, 55 of the 56 applied for and received matching grant awards.
Individual state awards reported in the first week of October: Pennsylvania $18.7 million, New York $15.2 million (of which $11,686,543 base and $3,490,344 match), Indiana $13,582,593, Wisconsin $11,441,359, Oklahoma over $9.5 million, West Virginia $8.1 million, Iowa $8 million, Missouri $7,434,869, Idaho roughly $5 million, the U.S. Virgin Islands $1.6 million.
This is a genuinely counter-cyclical story in a year with very few of them, and it is counter-cyclical for a specific structural reason that is worth understanding whether or not you work in maternal and child health: MIECHV is mandatory funding with a statutory escalator, not discretionary funding subject to annual appropriations. Nobody at OMB has to apportion it. No political appointee has to approve a competition. The statute says the money appropriates itself, and it does.
That protection has an expiration date of September 30, 2027.
Where the $525 million actually comes from
Most coverage of these awards reports the $525 million figure and stops. The arithmetic behind it is the useful part, because it tells you how much money is actually in play and where the rest of it sits.
MIECHV was established by Section 511 of the Social Security Act, added by the Patient Protection and Affordable Care Act (P.L. 111-148). It was most recently reauthorized by the Jackie Walorski Maternal and Child Home Visiting Reauthorization Act of 2022 (§6101 of the Consolidated Appropriations Act, 2023, P.L. 117-328), which set mandatory appropriations for FY2023 through FY2027 and — this was the structural innovation — split them into two separate streams:
| Fiscal Year | Base Grants | Matching Grants | Total |
|---|---|---|---|
| FY2023 | $500M | $0 | $500M |
| FY2024 | $500M | $50M | $550M |
| FY2025 | $500M | $100M | $600M |
| FY2026 | $500M | $150M | $650M |
| FY2027 | $500M | $300M | $800M |
So the FY2026 statutory total is $650 million, and $525 million shipped to the 56 jurisdictions. The gap is not slippage. The statute reserves money off the top before anything is allotted:
- 6% for tribal entities (doubled from 3% in the 2022 reauthorization; HHS awards these through competitive cooperative agreements, not formula)
- 2% for technical assistance
- 2% for home visiting workforce activities
- 3% for research, evaluation, and federal administration
That is 13% off the top — roughly $84.5 million of a $650 million year. And mandatory MIECHV funding has been subject to sequestration in certain years; the CRS note on FY2024 is instructive, showing a post-sequester total of $518.7 million against a $550 million statutory level, about a 5.7% haircut.
Run it: $650M less a ~5.7% sequester is about $613M; less 13% in set-asides is about $533M. "More than $525 million" to the 56 non-tribal recipients reconciles cleanly. The headline number is the residual after set-asides and sequestration, and you should expect the same structure in FY2027 — meaning the $800 million statutory year likely lands somewhere near $650–$660 million for states and jurisdictions.
Which is a roughly $125 million increase in available formula and matching funds next year. That is the single most actionable fact in this article.
The matching grant is the competitive variable, and 55 of 56 is the tell
Base grants are formula money. The statute distributes them according to each entity's share of children under age 5 and its FY2021 formula grant amount, and in practice the formula "adjusts but approximately maintains" each jurisdiction's FY2021 share. You cannot compete for base grants. They arrive.
Matching grants are different, and they are where the growth is: from $0 in FY2023 to $300 million in FY2027.
The terms: 75% federal, 25% non-federal — $3 in federal funds for every $1 in qualifying non-federal contribution, up to a ceiling. Each entity is eligible for a minimum matching amount plus a share of the remaining pool based on its share of children under 5 living in poverty. The statutory minimum matching award has escalated on its own schedule: $776,000 in FY2024, $1 million in FY2025, $1.5 million in FY2026, $2 million in FY2027. And there is a reallocation procedure for unclaimed matching funds — if a jurisdiction does not put up its 25%, its share goes to the ones that did.
So read "55 of 56 recipients claimed matching funds" correctly. That is not a participation statistic. That is 55 state agencies each having found non-federal dollars in a year when state budgets were tight, because every $1 they found returned $3. A 300% return on a state general-fund dollar is the best leverage in federal early-childhood policy, and the states have figured that out.
The remaining strategic question for FY2027 is whether any jurisdiction leaves money on the table when the pool doubles to $300 million. The minimum matching award alone rises to $2 million, meaning a jurisdiction needs roughly $667,000 in qualifying non-federal funds to claim the floor. For a small territory or a state in fiscal distress, that is a real constraint — and under the reallocation procedure, every unclaimed dollar flows to jurisdictions that did produce a match.
How a local nonprofit actually gets into this money
Here is the part that most readers of this site need, because MIECHV is not a program you apply to on Grants.gov as a community organization.
The recipient is the state. Specifically, the state's public health or social services department is the lead agency. The relevant notice of funding opportunity, HRSA-26-091, is written for states, DC, the five territories, and tribal entities. If you are a local nonprofit, a community health center, a hospital system, or a family-service agency, your path into MIECHV is almost always a subaward from the state lead agency, not a direct federal application.
Four exceptions and openings:
1. The non-applying-state provision. Under Section 511, HHS may make grants directly to nonprofit organizations to run home visiting in a state that did not apply for, or did not receive approval for, a grant. This is not theoretical: as of FY2022, nonprofit organizations were fully or partly administering MIECHV in Florida, North Dakota, and Wyoming. If you operate in a state with a weak or absent lead agency, this is a real and underused door.
2. Tribal set-aside competitions. The 6% tribal reservation — roughly $39 million in a $650 million year — is awarded through competitive cooperative agreements, not formula. As of FY2022, 36 tribal entities had ever received funding. This is a genuine open competition, and it is the one part of MIECHV where a non-state applicant competes head-to-head on merit.
3. Model developer and workforce money. The 2% workforce reservation and the 2% technical assistance reservation flow to model developers and TA providers through HHS contracts and grants.
4. Subrecipient positioning, which is the main event. States must spend a majority of MIECHV funds on home visiting models HHS has determined meet its evidence criteria — 23 models qualified as of FY2023. The most widely implemented, per HRSA's state fact sheets, are Nurse-Family Partnership (37 states/territories), Healthy Families America (37), Parents as Teachers (35), Early Head Start Home-Based Option (12), and HIPPY (5). States may use up to 25% of funds on "promising" models they rigorously evaluate themselves, and up to 25% on pay-for-outcomes initiatives.
If you want to become a MIECHV subrecipient, the practical sequence is: get credentialed in one of the 23 approved models for your state's portfolio; read your state's most recent statewide needs assessment (states must submit these to HHS with explanations of how identified needs will be addressed, and they name the specific high-risk communities with service gaps); and approach the lead agency with a proposal to serve a community the assessment already flagged. You are not persuading the state that a need exists. You are volunteering to cover a gap the state has already told the federal government about in writing.
The compliance structure, because it shapes what states will subcontract
Three statutory features determine what a state agency can and will push down to you.
Benchmarks. Jurisdictions must demonstrate improvement in at least four of six statutory benchmark areas — health, child maltreatment, academic readiness, crime and safety, economic self-sufficiency, and community referrals — measured since FY2017 across 19 specific items. Failure requires an HHS-approved corrective action plan, with grant termination as the backstop. In FY2020, every state and territory entity met the requirement. The consequence for subrecipients: states will contract with partners who can produce clean benchmark data on schedule, and they will be conservative about partners who cannot. Your data infrastructure is a competitive asset in this program, not overhead.
The 10% administrative cap. Recipient administrative costs are generally limited to no more than 10% of funding. Expect a tight indirect posture in any subaward, and build your budget accordingly rather than arguing about it later.
Two-year obligation window and maintenance of effort. Entities may expend MIECHV funds through the end of the second succeeding fiscal year after award — so FY2026 money is live through FY2028. That is a genuine planning advantage: a state can commit to a multi-year subaward without a September cliff. Separately, entities must meet a maintenance-of-effort requirement to receive any grant funding at all, which means states cannot substitute MIECHV dollars for their own existing home-visiting spending.
The 2027 cliff, and why the next twelve months are the window
MIECHV's authorization and mandatory funding run through FY2027 and then stop. Congressional action is required to continue the program past September 2027.
The signals so far are encouraging rather than secured. The House Ways and Means Work and Welfare Subcommittee held a hearing on June 25, 2026, specifically to assess MIECHV implementation and build momentum for reauthorization, chaired by Rep. Darin LaHood. The committee's own follow-up framed the hearing around program effectiveness and bipartisan support. Members emphasized the evidence base — and MIECHV has an unusually strong one for a social program, including the congressionally mandated Mother and Infant Home Visiting Program Evaluation (MIHOPE), a large-scale random-assignment study that found programs were well implemented, primarily reached at-risk families, and produced positive effects on some outcomes at 15 months, with longer-term follow-up ongoing.
Scale, for the reauthorization argument: in FY2025, MIECHV delivered more than one million home visits to roughly 158,000 parents and children across nearly 79,000 households, reaching about one-third of all U.S. counties. Pre-pandemic estimates put MIECHV's reach at 3–5% of eligible families.
For anyone planning around this program, the sequencing is clear enough:
- FY2027 is the biggest authorized year — $800 million statutory, likely $650M-plus to jurisdictions. If you want to be in that money, the state-level conversation has to happen in the next two quarters, not next summer. State lead agencies are planning FY2027 subaward portfolios now.
- Do not build a model that assumes FY2028 MIECHV revenue. It may well materialize — bipartisan support for this program is real and durable — but it is not currently authorized, and an organization that has hired against unauthorized funding is an organization with a staffing cliff.
- The reauthorization ask on the table is larger than the current level. The National Home Visiting Coalition's position going into the 2022 reauthorization was a $200 million annual escalator reaching $1.4 billion; the enacted law landed at $800 million by FY2027. The gap between the advocacy ask and the enacted number is the range to watch in the next bill.
The broader lesson
MIECHV is having its best year in a year when NSF left $1.7 billion unobligated and the DOE Office of Science cut its annual open call by 20%. The difference is not political popularity. It is statutory architecture: mandatory appropriations with a written escalator, a formula allotment nobody has discretion over, and a matching structure that recruits state money into the program automatically.
If you fund your organization primarily through discretionary federal competitions, the FY2026 record is a reason to go find out which of the programs in your field are mandatory and which are discretionary. In this environment that distinction is doing more work than program quality, agency relationships, or proposal craft.
Sources: HRSA, HRSA Awards More Than $525 Million for Home Visiting · HRSA-26-091, MIECHV Base and Matching Grant Awards · CRS IF10595, Maternal, Infant, and Early Childhood Home Visiting Program · First Five Years Fund, Making News: MIECHV Grants 2026 · House Ways and Means, MIECHV hearing, June 25, 2026 · HRSA MCHB, MIECHV program page